Expression of apoptosis-associated protein RCAS1 in macrophages of histiocytic necrotizing lymphadenitis

Yasunobu Abe1, Koichi Ohshima, Manabu Nakashima

  • 1Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. abey@intmed3.med.kyushu-u.ac.jp

Insights

Receptor-binding cancer antigen (RCAS1) on macrophages is elevated in histiocytic necrotizing lymphadenitis. This suggests RCAS1 may induce T-cell apoptosis in this condition.

Area of Science:

  • Immunology
  • Oncology
  • Pathology

Background:

  • Receptor-binding cancer antigen expressed on SiSo cells (RCAS1) is found on various cancer cells.
  • RCAS1 is an apoptosis-associated protein affecting T-cells and erythroid progenitor cells.
  • Monocytes/macrophages have been previously shown to express RCAS1.

Purpose of the Study:

  • To investigate RCAS1 expression in histiocytic necrotizing lymphadenitis (HNL).
  • To determine the role of RCAS1 in HNL pathogenesis, particularly T-cell apoptosis.

Main Methods:

  • Immunohistochemical staining using the 22-1-1 monoclonal antibody (MoAb) was performed.
  • RCAS1 expression was analyzed in 9 HNL cases and 9 reactive lymphadenitis controls.
  • The ratio of RCAS1+ cells to CD68+ cells (monocytes/macrophages) was quantified.

Main Results:

  • RCAS1 expression was significantly higher in HNL cases compared to controls.
  • The ratio of RCAS1+ cells to CD68+ cells was significantly elevated in HNL (P = .0002).

Conclusions:

  • RCAS1 is expressed on macrophages in HNL.
  • Macrophages expressing RCAS1 may contribute to the induction of T-cell apoptosis in HNL.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.